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Abstract 
Background. Post-stroke Shoulder Pain (PSSP) is a common stroke-related syndrome that prolongs 
hospitalization and diminishes quality of life. PSSP studies were unsuccessful in clarifying 
pathophysiological mechanisms. Therefore, cohort's studies with greater variety of the sample and larger 
follow-up period could provide additional clinical data and may improve medical care. 
Objective. To classify people with PSSP and identify intergroup clinical differences, providing additional data 
useful for therapeutic care planning. 
Methods. One thousand individuals with stroke were selected from all levels of one health Area and followed 
up during one year. Demographic data, stroke clinical characteristics, stroke-related symptoms and 
rehabilitation parameters were collected. The shoulder muscle impairment was used to group participants into 
three clinical profiles: severe muscular impairment, moderate muscular impairment and low muscular 
impairment groups. 
Results. A total of 119 individuals were diagnosed with PSSP. The suggested classification criteria showed 
two groups that differed significantly in relation to the onset and duration of PSSP, presence of sensory and 
speech impairment, and spasticity. The outcomes did not firmly support the existence of a third suggested 
PSSP subtype. 
Conclusions. PSSP may vary in onset, clinical manifestations, severity and syndrome duration. These results 
highlight the course of different clinical profiles and require multidisciplinary management approaches. 
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Introduction 
Post-stroke Shoulder Pain (PSSP) is a common and disabling complication of stroke,1, 2 which is 
described as any subjective complaint of pain in the contralesional, or affected, shoulder following 
stroke.3, 4 This syndrome has been associated mainly with reduced upper limb motor function, 
shoulder subluxation, spasticity or capsular disorders, rotator cuff injuries, thalamic syndrome and 
shoulder-hand syndrome.5, 6, 7, 8, 9 The incidence of PSSP varies between 22% and 60%, depending 
on the clinical characteristics of the stroke and study design.2, 4, 6, 7, 10, 11, 12 This syndrome has been 
established as one of the most important complications of stroke,1 interfering with rehabilitation 
care and activities of daily living.13, 14 
 
Previous studies proposed several models for accurate physical therapeutic care, but none showed 
suitable results for all sample cohorts regarding arm functional recovery and pain resolution. The 
occurrence of a wide variety of symptoms and the relative contributions of various factors to the 
development of PSSP11, 12 suggest that this condition may not manifest itself as a unique entity 
with its own clinical characteristics or vary considerably during the different stages of stroke. 
 
There is still a great need for studies on the possible etiologic disparity of this stroke-related 
syndrome, particularly on PSSP with well-defined objective classification criteria. An extended 
follow-up period and a wide variety in the sample cohort may yield additional data, leading to 
deeper knowledge of the pathophysiology of PSSP.15 Such a study could result in a better 
classification of these clinical characteristics into different clinical profiles leading to accurate 
assessment and individual treatment for individuals with PSSP. The aim of this investigation was 
to classify people with PSSP and identify intergroup clinical differences, providing additional data 
that might improve the physical therapeutic management. 
Methods 
Subjects 
Subjects with stroke admitted to the hospital and attended at any level of our Health Area (e.g., 
neurology, rehabilitation, internal medicine and primary care departments) were selected. The 
exclusion criteria was a clinical history of recurrent shoulder pain events (more than one episode 
over a year), or one referred episode of shoulder pain in the three months prior to stroke. 
Individuals diagnosed with behavioural disorders or neurological symptoms like anosognosia, 
hemineglect, Parkinson's disease and Alzheimer's disease, which could complicate evaluation, 
were also excluded. Participants who did not complete the one-year follow-up period were also 
excluded. 
Study design 
This prospective observational study was conducted in a mixed metropolitan and rural region with 
an estimated population of 500,000 individuals. A total of 1000 subjects diagnosed with stroke and 
admitted to the hospital in first 24 h post-stroke were screened for eligibility by continuous 
sampling over one year. The appropriate study sample size was calculated based on a maximum 
loss of screened participants of 49%16 and a minimum incidence of PSSP of 22%7 as reported in 
previous studies. This means that the minimum sample to be analyzed would be at least 100 cases 
of PSSP. 
  
The information of interest to the study included clinical data and medical care parameters. All 
assessments and diagnoses were made by the attending physicians, who recorded the clinical 
findings in their medical files. The contributing neurologists verified all the documented study-
related clinical characteristics and diagnosed the PSSP syndrome during hospital stays or stroke 
appointments. The follow-up period was established in accordance with previous 
studies17, 18 which considered first year after stroke the PSSP onset period. The participants had 
three stroke appointments during the study period: at 3, 6 and 12 months. Once patients had been 
assessed, a trained physical therapist reviewed their medical files to collect the information for the 
study, entering into a custom-designed database. Clinical data were collected through the IANUS 
Corporative Information System, which provides information from every healthcare department 
for each participant. 
 
The Clinical Research Ethics Committee of Galicia (CEIC) approved the free access to medical 
files (A.R. 2013/440; Santiago de Compostela, Galicia, Spain) according to the principles 
established in the Declaration of Helsinki and medical research legislation. Patients signed the free 
informed consent to collect their clinical data necessary for the present study. 
Procedures 
Stroke clinical characteristics (stroke type and classification, affected cerebral hemisphere and 
contralesional side of the body) and stroke-related symptoms (presence of speech and sensory 
impairment, impaired shoulder muscle function and involuntary movements) were collected from 
the initial evaluation of participants’ files. Stroke was classified using the TOAST and Oxfordshire 
Community Stroke Project – ischaemic stroke – and haemorrhagic stroke classification 
scale.19, 20, 21 
 
Hemineglect was detected using item 11 of National Institute of Health Stroke 
Scale (NIHSS)22 and guideline drawing, while communication deficits were identified using items 
12 and 13 of this scale.22 The sensory exam, including pain, light touch and proprioceptive 
sensation, was assessed in both arms, testing first on the unaffected side (C5 dermatome). The 
light touch impairment was determined using a needle and brush over the higher and lower part of 
the middle deltoid muscle. Proprioception was tested at the thumbs assessing joint position 
sense.9 All testing was performed 3 times on each side. Participants indicated whether the 
sensation was the equal, diminished, or non-existent compared to the unaffected side. Based on 
test values, the sensation deficit was classified as anaesthesia or hypoesthesia. 
 
Upper limb motor function was assessed using Daniels manual muscle testing23, 24, 25 (MMT). 
Shoulder muscle function was assessed on the muscle groups most closely associated with PSSP: 
the main flexor, external rotator and abductor muscles.26 The final value was obtained by 
calculating the mean of the MMT scores for the assessed muscle groups. 
 
As the changes in motor control are the most common stroke clinical sign27; muscle function was 
used as the sort variable to obtain a rating system for PSSP profiles. Indeed, cross-sectional studies 
showed an association between decreased motor function and PSSP clinical characteristics, 
suggesting that a new PSSP classification model using upper extremity motor function as the sort 
variable is possible.28 
  
Rehabilitation parameters collected included proportion of subjects referred, pain response to 
treatment-recorded using a visual analogue scale (VAS) – and duration of follow-up. The 
assessments performed during the follow-up period (hospital stay and after discharge) provided 
information on the presence of stroke symptoms such as spasticity, involuntary movements 
and neuropathic pain. As several physicians would be responsible for their diagnosis, these 
assessments could involve evaluation bias. In order to prevent it, spasticity was first assessed by 
Ashworth scale,24, 25, 29 and subsequently dichotomized as presence or non-existence of spasticity. 
Because of the lack of specific diagnostic criteria for neuropathic pain, the diagnosis was based on 
criteria exposed by a group of experts from the neurologic and pain community30: Neuropathic 
pain was defined as “pain arising as a direct consequence of a lesion or disease” and its diagnosis 
required the presence of pain with a distinct plausible distribution, a history suggestive of a 
relevant lesion, indication of negative or positive sensory signs within the area, and confirmation 
of the lesion by a diagnostic test. Furthermore, involuntary movement's diagnosis was also based 
on a previous grading system.31 
 
A consensus assessment was used to diagnose PSSP. Patient – or caregiver – reported the 
occurrence of pain in the contralesional shoulder and the attending physician confirmed a 
compatible clinical profile: deep pain on the stroke-affected shoulder that gradually increases and 
persists at rest, and is aggravated by active or passive movement.32, 33 The contributing 
neurologists verified the diagnosis of PSSP after ruling out other possible causes of pain, such as 
traumas, central post-stroke pain30 (CPSP) or complex regional pain syndromes.34 The onset of 
PSSP was recorded as the individual's first report of shoulder pain, even if the PSSP diagnosis was 
delayed. Data related to PSSP development were also collected: time of onset, detection stage and 
duration. 
 
Pain-related characteristics (duration of PSSP and pain response to treatment) were assessed 
according to the individual's ability to communicate (by verbally or physically marking the VAS 
value). 
Statistical analysis 
Data analysis was performed in Statistical Package for Social Science (SPSS) v 20.0 and R 
software (rcompanion package) v 3.5.1, considering statistically significant the p-values inferior to 
0.05. 
 
Stroke clinical characteristics (stroke type, stroke classification, affected cerebral hemisphere and 
contralesional body side), stroke-related symptoms (presence of speech and sensory impairment, 
involuntary movements, spasticity, neuropathic pain) and PSSP data (detection stage and response 
of pain to physical therapy) were codified as qualitative variables and described using frequencies 
and percentages. Spasticity variable was dichotomized as presence (Ashworth scores > 0) or non-
existence (Ashworth score = 0) of spasticity. PSSP was ranked using muscle function (MMT 
grades) as a sort variable. The Chi-square test was used to identify association between variables 
and PSSP groups. 
 
Quantitative variables (PSSP onset and duration, neuropathic pain onset, physical therapy follow-
up duration) are described as means and standard deviation (SD), using days as the unit of 
measurement. One-way ANOVAs were used to compare means among three clinical profiles 
according to MMT grades after assessing for normal distribution with the Kolmogorov–Smirnov 
test. The Chi-square pairwise test and Tukey's honestly significant difference (HSD) were used 
for post hoc analysis of the qualitative and quantitative variables, respectively, when necessary. 
Additionally, a modified Kaplan–Meier function was used to compare the PSSP onset according to 
the degree of shoulder muscle impairment. 
  
Results 
The inclusion criteria were met by 576 participants (252 women, 324 men; mean age 70 ± 13 
years). The sample includes 434 individuals with ischaemicstroke and 142 with haemorrhagic 
stroke. A total of 119 participants (21%) were diagnosed with PSSP, which were grouped by the 
degree of shoulder muscle impairment into three clinical profiles according to MMT grades (Fig. 
1): 
 
• MMT grade 0–1; severe muscle impairment (SMI): 46 individuals (37%), 
• MMT grade 2–3; moderate muscle impairment (MMI): 29 individuals (24%) and 





Figure 1. Flow chart of sample. Abbreviations: PSSP, post-stroke shoulder pain; SMI, severe muscular 
impairment; MMI, moderate muscular impairment; LMI, low muscular impairment.  
Clinical characteristics of stroke: stroke type, classification scales, affected cerebral 
hemisphere and contralesional body side 
Although analyses revealed right cerebral hemisphere and left contralesional body side affected 
seem to be more frequent in subjects with severe muscle impairment, no clinical characteristics of 
stroke showed significant differences among the groups of participants with PSSP. 
 
The clinical characteristics of stroke in subjects with PSSP are shown in Table 1. 
Stroke-related symptoms: speech and sensory impairment, presence of involuntary 
movements, spasticity and neuropathic pain 
Individuals with sensory impairment comprised 59% (n = 70). The analysis showed that the 
proportion of individuals with sensory impairment diminished according with lower impairment of 
shoulder muscle function, highlighting differences (p < 0.001) between SMI (78%) and LMI 
(36%) groups. Hypoesthesia was the most common sensory impairment among the different 
groups. 
 
Individuals with speech impairment comprised 56% (n = 67) of the total PSSP sample. The post 
hoc test confirmed significant differences (p = 0.003) for incidence of speech impairment between 
LMI (41%) and SMI (74%) groups. 
 
Analysis showed differences in spasticity between PSSP clinical profiles (p < 0.001), and post hoc 
test specified significant differences of SMI versus LMI (p < 0.001) and MMI (p = 0.003) groups. 
Neuropathic pain was detected in 36% of the participants with PSSP with similar incidences 
among the groups (28–39%), showing no significant differences between groups (p = 0.544). The 
incidence of involuntary movements showed a trend but not significant association with PSSP 
groups (p = 0.07). 
 




Table 1. Clinical characteristics of stroke in participants with PSSP in relation to the degree of muscle impairment. 
 
SMI Group (n = 46)  
n (%) [95% CI] 
MMI Group (n = 29)  
n (%) [95% CI] 
LMI Group (n = 44)  
n (%) [95% CI] 
p-Value 
     
Stroke type: ischaemic 32 (70) [55.18–83.95] 22 (76) [58.56–93.16] 37 (84) [72.18–96.03] 0.182 
Affected cerebral hemisphere: right (n = 65) 29 (63) [48.00–78.08] 16 (55) [35.35–74.99] 20 (45) [29.61–61.30] 0.285 
Contralesional body side: left (n = 56) 28 (61) [45.68–76.06] 13 (45) [25.00–64.65] 15 (34) [18.95–49.23] 0.489 
Individuals with ischaemicstroke (n = 91)     
TOAST scale:    –  
Large-artery atherosclerosis (n = 58) 25 (54) [38.87–69.83] 14 (48) [28.36–68.19] 19 (43) [27.41–58.95]  
Cardioembolism (n = 4) 1 (2) [0.05–11.53] 1 (3) [0.09–17.76] 2 (5) [0.55–15.47]  
Small-vessel occlusion (n = 29) 5 (11) [3.62–23.57] 7 (24) [6.84–41.44] 17 (39) [23.11–54.16]  
Oxfordshire Community Stroke    – 
Project scale:     
TAC (n = 6) 6 (13) [2.22–23.86] 0 0  
PAC (n = 49) 20 (43) [28.07–58.89] 14 (48) [28.36–68.19] 15 (34) [18.95–49.23]  
LAC (n = 27) 5 (11) [3.62–23.57] 6 (21) [7.99–39.72] 16 (36) [21.01–51.71]  
POC (n = 9) 0 2 (7) [0.85–22.77] 7 (16) [3.96–27.85]  
Individuals with haemorrhagic stroke (n = 32)      
Lesion area:       
Deep intracerebral haemorrhage (n = 11) 9 (20) [7.01–32.12] 2 (7) [0.85–22.77] 0 – 
Lobar intracerebral haemorrhage (n = 7) 4 (9) [2.42–20.79] 1 (3) [0.09–17.76] 2 (5) [0.55–15.47] – 
Brainstem haemorrhage (n = 2) 0 1 (3) [0.09–17.76] 1 (2) [0.06–12.02] – 
Intraventricular haemorrhage (n = 2) 2 (4) [0.53–14.84] 0 0 – 
Subarachnoid haemorrhage (n = 5) 1 (2) [0.05–11.53] 2 (7) [0.85–22.77] 2 (5) [0.55–15.47] – 
Subdural haemorrhage (n = 5) 2 (4) [0.53–14.84] 1 (3) [0.09–17.76] 2 (5) [0.55–15.47] – 
     
 
Abbreviations: SMI, severe muscle impairment; MMI, moderate muscle impairment; LMI, low muscle impairment; CI, confidence intervals; TOAST, trial or Org 10172 in acute 
stroke treatment; TAC, total anterior circulation stroke; PAC, partial anterior circulation stroke; LAC, lacunar stroke; POC, posterior circulation stroke. 
The first column of the table shows variables and their total number of cases (n). The values of the stroke characteristics are expressed as frequency (percentage) and CI. Analysis 
of the stroke classification scales was not possible because the sample size was insufficient in several subcategories for the Chi-square and Fisher exact tests. 
  
Table 2. Stroke-related symptoms in participants with PSSP in relation to the degree of muscle impairment. 
 SMI group (n = 46) 
n (%) [95% CI] 
MMI group (n = 29) 
n (%) [95% CI] 
LMI group (n = 44) 




      
Sensory impairment (n = 70) 36 (78) [65.25–91.27] 18 (62) [42.68–81.45] 16 (36) [21.01–51.71] <0.001 <0.001a 
Sensory impairment type:    0.002 0.010a 
Anaesthesia (n = 14) 12 (26) [12.31–39.86] 2 (7) [0.85–22.77] 0   
Hypoesthesia (n = 54) 23 (50) [34.46–65.54] 16 (55) [35.35–74.99] 15 (34) [18.95–49.23]   
Speech impairment (n = 67) 34 (74) [60.14–87.69] 15 (52) [31.81–71.63] 18 (41) [25.24–56.57] <0.001 0.003a 
Involuntary mov. (n = 20) 6 (13) [2.22–23.86] 9 (31) [12.47–49.60] 5 (11) [3.79–24.56] 0.070  
Spasticity (n = 25) 21 (46) [30.17–61.13] 3 (10) [2.19–27.35] 1 (2) [0.06–12.02] <0.001 <0.001a 
     0.003b 
Neuropathic pain (n = 43) 18 (39) [23.94–54.32] 8 (28) [9.59–45.57] 17 (39) [23.11–54.16] 0.544  
 Mean ± SD Mean ± SD Mean ± SD   
Onset of neuropathic pain (d) 73.33 ± 40.82 74.44 ± 87.73 163.65 ± 184.32 0.457  
      
 
Abbreviations: SMI, severe muscle impairment; MMI, moderate muscle impairment; LMI, low muscle impairment; CI, confidence intervals; mov., movements; SD, standard 
deviation. 
The first column of the table shows variables and their total number of cases (n). The values of the stroke-related symptoms are expressed as incidence (percentage) and CI. The 
time elapsed before the onset of neuropathic pain after stroke is expressed as mean ± standard deviation in days (d). 
When Chi-square or One way ANOVA analysis showed p < 0.05, post hoc tests specified significant differences (right column) between SMI and LMI groups (a) or SMI and 
MMI groups (b). 
PSSP characteristics and response to treatment 
Table 3 shows the PSSP characteristics and response to treatment of patients with the syndrome. 
PSSP onset analysis showed association (p = 0.005) with the degree of shoulder muscle 
impairment (Fig. 2), revealing post hoc test significant differences (p = 0.007) between SMI and 
MMI groups (Table 3). PSSP onset analysis also showed relevant values but inconclusive 




Figure 2. Kaplan–Meier analysis of PSSP onset in relation to the intensity of shoulder muscle 
impairment. Abbreviations: K-M, Kaplan–Meier; SMI, severe muscle impairment; MMI, moderate muscle 
impairment; LMI, low muscle impairment. 
 
Table 3. PSSP characteristics and response to treatment in relation to the degree of muscle impairment. 
 SMI group (n = 46) MMI group (n = 29) LMI group (n = 44) p-Value Intergroup differences  
 Mean ± SD Mean ± SD Mean ± SD  p-value 
      
PSSP onset (d) 90.02 ± 81.25 69.00 ± 59.82 176.02 ± 150.73 0.005 0.007b 
 n (%) [95% CI] n (%) [95% CI] n (%) [95% CI]   
PSSP stage of detection:    <0.001 0.001a 
     0.022c 
Hospital stay (n = 53) 30 (65) [50.37–80.07] 13 (45) [25.00–64.65] 10 (23) [9.21–36.25]   
Rehab. follow-up period (n = 30) 13 (28) [14.16–42.36] 8 (28) [9.59–45.57] 9 (20) [7.40–33.51]   
Primary care follow-up (n = 35) 3 (7) [1.37–17.90] 7 (24) [6.84–41.44] 25 (57) [41.05–72.59]   
Physical therapy (n = 69) 42 (91) [79.21–97.58] 18 (62) [42.68–81.45] 9 (20) [7.40–33.51] <0.001 0.001a 
     0.005b 
     <0.001c 
Response to treatment:    0.281  
Pain resolution (n = 35) 11 (24) [10.50–37.33] 7 (24) [6.84–41.44] 17 (39) [23.11–54.16]   
Diminished pain (n = 33) 12 (26) [12.31–39.86] 9 (31) [12.47–49.60] 12 (27) [12.98–41.57]   
Persistent pain (n = 32) 17 (37) [21.92–51.99] 7 (24) [6.84–41.44] 8 (18) [5.65–30.71]   
PSSP follow-up duration:    0.074  
Less than 3 months (n = 35) 9 (20) [7.01–32.12] 10 (43) [15.46–53.51] 16 (47) [21.01–51.71]   
3–6 months (n = 15) 5 (11) [3.62–23.57] 4 (17) [3.89–31.66] 6 (18) [2.36–24.91]   
6–9 months (n = 27) 11 (24) [10.50–37.33] 6 (26) [7.99–39.72] 10 (29) [9.21–36.25]   
More than 9 months (n = 18) 13 (28) [14.16–42.36] 3 (13) [2.19–27.35] 2 (6) [0.55–15.47]   
      
 
Abbreviations: SMI, severe muscle impairment; MMI, moderate muscle impairment; LMI, low muscle impairment; SD, standard deviation; CI, confidence intervals; PSSP, post-
stroke shoulder pain. 
The first column of the table shows variables and their total number of cases (n). PSSP onset values are expressed as mean ± standard deviation in days (d). The remaining values 
are expressed as incidence (percentage) and CI. 
When Chi-square or One way ANOVA analysis showed p < 0.05, post hoc tests (right column) specified significant differences between SMI and LMI groups (a), SMI and MMI 
groups (b) or MMI and LMI groups (c). 
 
 
Analysis of the stage of PSSP detection revealed significant differences between groups 
(p < 0.001). Majority (65%) of the SMI group was diagnosed during the hospital stay; whereas the 
incidence of cases diagnosed during this stage fell to 45% of the MMI group and 23% of the LMI 
group. This trend reversed with primary care PSSP detection; showing LMI incidences significant 
higher than SMI (p < 0.001) and MMI (p = 0.022) groups. 
 
Analysis of subjects with PSSP (n = 69, 58%) who received care in the physical therapy 
department showed significant values (p < 0.001), specifying post hoc test significant differences 
between all PSSP groups (p < 0.006). 91% of the SMI group received physical therapy, whereas 
only 20% of the LMI group received this treatment. The MMI group showed intermediate 
proportions (62%). Pain resolved during the rehabilitation period in 29% (n = 35) of patients with 
PSSP, showing the highest incidence of pain resolution in LMI group (39%). 37% of the SMI 
group experienced persistent pain of the same intensity, in contrast with 18% of LMI group. The 
duration of PSSP required follow-up periods of more than six months in 52% of the individuals 
with SMI (n = 45); 28% of this group was followed up for at least 9 months. MMI and LMI groups 
ended follow-up period at six months in 60% and 65% of cases respectively. Although the analysis 
showed no significant values, the follow-up period required tended (p = 0.074) to be prolonged in 
the SMI group, in contrast with the LMI group. 
Discussion 
The primary aim of this study was to classify people with PSSP and identify intergroup clinical 
differences. Thus, this study analyzed the course of the syndrome and evidenced different possible 
clinical presentations. 
 
PSSP was diagnosed in 119 patients. The suggested method allowed grouping the participants into 
three different clinical profiles: individuals with severe muscle impairment, moderate muscle 
impairment and low muscle impairment. Although several models35 can be used to evaluate 
shoulder muscle impairment, few scales are commonly employed for initial evaluation of stroke 
patients, mainly highlighting NIHSS and MMT based on Medical Research Council and Daniels 
scales.24, 25 A recent study3 classified the shoulder muscle impairment variable using the item on 
the NIHSS scale, but it did not include patients with motor function preserved; did not cover all 
possible muscle function grades and possible PSSP profiles. Thus, we finally decided to use the 
Daniels scale, which is a simple technique commonly used by physicians and globally tolerated by 
patients with severe clinical profiles.36 This manual muscle testing version provides reliable results 
of muscle groups’ assessment of acute stroke patients.24 In addition, this scale may ensure the 
inclusion of all possible PSSP profiles. 
 
The suggested classification system revealed the existence of two independent PSSP profiles that 
differed significantly in their clinical characteristics. Although an intermediate profile (MMI) was 
suggested, our outcomes do not support the existence of a third PSSP subtype; remaining 
necessary that further studies clarify this point. This PSSP sub-classification may help to explain 
the conflicting results of previous reports,14, 33, 37, 38, 39 where authors attributed the wide variety of 
clinical descriptions to sample cohort's differences, health areas included and stroke stage. In this 
context, we enrolled a mixed group by recruiting subjects followed up at any level of healthcare, 
extending the data collection period to first post-stroke year. 
  
Regarding stroke main clinical characteristics, our results suggest that stroke type and laterality do 
not seem to be associated to the development of different PSSP profiles. This information 
contrasts with findings from previous authors7 who claimed that stroke type might be associated 
with PSSP. In accordance with some authors,2, 9, 14, 18, 26, 30, 32 we consider that stroke type is not 
associated with PSSP, but some stroke-related complications might modulate the onset and course 
of the syndrome. Our results are in line with this assumption since they showed significant 
differences in stroke-related symptoms between PSSP groups. Thus, the adoption of a 
management based on the assessment of some stroke symptoms in the early stage of stroke might 
improve results. Further testing is required to determine if this alternative method can enhance the 
current approach. 
 
In addition, the high proportion of individuals with right cerebral hemisphere lesion and left 
contralesional body – significantly more frequent in subjects with hemineglect – suggests a 
possible association between hemineglect and PSSP.9, 37 Hemineglect was considered an exclusion 
criterion because it could interfere with the evaluation of pain,22 so further studies are needed to 
complement our data. 
 
Our results revealed participants with severe muscle impairment were diagnosed with PSSP in the 
first 3 months post-stroke, showing a rapid onset and progression, and developing into a long-term 
syndrome. This PSSP profile was also associated with high rate of sensory deficit, speech 
impairment and spasticity. This PSSP group seems to include the population 
with hemiplegic shoulder pain3, 14, 15, 33 (HSP). Additionally, these clinical characteristics coincide 
with the results showed by Roosink et al.,40 who provided information about persistent Post-stroke 
Shoulder Pain (pPSSP). This previous study exposed that pPSSP might be caused by central 
lesions affecting somatosensory pathways as well as ongoing nocioceptive input from the 
shoulder, leading finally to central nervous system sensitization. Lin et al.41 also reported central 
sensitization might be caused by input from hemiparetic pain, but other mechanisms such as brain 
damage from the stroke itself or an abnormality in muscle balance could also contribute. These 
arguments support that both spasticity as severe motor impairment and altered kinematic 
movement caused by sensitive deficit and postural imbalance could lead to central sensitization, 
explaining the long term PSSP subtype. Nevertheless, we did not perform specific analysis to 
assess somatosensory sensitization. To provide conclusive results on pathogenesis of this PSSP 
subtype, further studies on lesion cerebral area and affected pathways should be performed. 
 
The present study also reported patients with low muscle impairment (LMI) who had a delayed 
onset of PSSP and a short-term syndrome with less than three months. LMI cases had a lower 
incidence and severity of sensory deficit and speech impairment. Only one case of spasticity was 
detected in this group. 
 
Analysis revealed that most SMI cases were diagnosed by hospital departments, particularly the 
rehabilitation department; the majority of them receiving physical therapy. Primary care is mainly 
where PSSP is detected in patients with LMI, and few patients received physical therapy. 
However, the SMI group had a high rate of persistent pain in contrast with the LMI group. These 
percentages reinforce the need for modified physical therapy in patients with severe stroke-related 
symptoms42; including early and targeted management, and long-term daily 
care.3, 11, 15, 43, 44 Individuals with LMI showed appropriate response to standard treatment, but the 
proportion of patients who received physical therapy could clearly be improved. Their mild 
severity of the stroke symptoms and delayed onset of PSSP may explain the low number of 
referrals to physical therapy. Thus, to involve primary care departments by means of targeted 
protocols and predictive objective measures may improve PSSP identification and referral to 
rehabilitation services. They may not need an urgent rehabilitation approach, but a longer follow-
up including detailed shoulder kinematic tests45, 46 and trunk muscle strength assessment.47 Despite 
the importance reported by previous studies43, 48 on the intensity of the rehabilitation, physical 
therapy interventions could not be analyzed because we cannot guarantee that all participants with 
PSSP received the same approach and the data related to the procedures may be incomplete. 
Additionally, we focused pain assessment on pain related to glenohumeral movement – strongly 
associated with PSSP diagnosis – and response to treatment. Other pain-related measures 
(e.g. pressure pain threshold, heat pain threshold, conditioned pain modulation, etc.) were not 
taken account in the current study, so future studies could analyze this issue. 
 
Regarding neuropathic pain, our analysis showed incidence values higher than in the general 
population.39 Because the onset of neuropathic pain (three to six months after stroke) coincides 
with the rehabilitation period, previous studies12, 13, 49 suggested that neuropathic pain is related 
with physical therapy approach. Our analysis showed similar proportions of neuropathic pain in 
participants, regardless of whether they underwent physical therapy. This contrast in outcomes 
could be due to previous studies usually used inclusion criteria like health areas and 
hospitalization. Therefore, the development of neuropathic pain was independent of the physical 
therapy approach received by individuals with PSSP in this study. 
 
Since CPSP diagnosis was an exclusion criterion, we focused on identifying the CPSP clinical 
picture. According to previous reports,9, 30 CPSP diagnosis was based mainly in location of the 
lesion and sensory findings such as burning, painful cold, electric shocks, aching, pressing, 
stinging, etc. We cannot guarantee that all participants with CPSP were accurately diagnosed, 
despite intensive efforts. Although we recognize this bias in the diagnosis of PSSP, the incidence 
of CPSP in the post-stroke population is about 5–11%,50, 51, 52 so this confounding factor would be 
controlled. 
 
In conclusion, PSSP may not develop as a single entity with a unique clinical profile; instead, it 
varies depending on the characteristics of the subject and stroke phase. Our clinical findings 
showed that secondary classification of PSSP according to the degree of the muscle impairment of 
the affected shoulder is possible. These PSSP subtypes showed statistical differences in presence 
and type of sensory impairment, speech impairment, spasticity and PSSP onset. Contrary to 
expectations, stroke type and the affected brain area showed no association with the clinical 
characteristics of PSSP. 
 
Furthermore, individuals with PSSP present different clinical profiles that may need different 
therapeutic approaches involving different types of health professionals (mainly neurologists, 
rehabilitation specialists, physical therapists and general practitioners). Further research is required 
to clarify a practical range of preventive and therapeutic options for PSSP. 
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